Moody Aldrich Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Sell |
137,796
-2,109
| -2% | -$60.7K | 0.77% | 63 |
|
|
2025
Q1 | $4.69M | Sell |
139,905
-4,461
| -3% | -$150K | 0.98% | 38 |
|
|
2024
Q4 | $7.38M | Buy |
144,366
+5,236
| +4% | +$268K | 1.37% | 16 |
|
|
2024
Q3 | $7.11M | Sell |
139,130
-11,053
| -7% | -$565K | 1.29% | 23 |
|
|
2024
Q2 | $6.73M | Buy |
150,183
+93,781
| +166% | +$4.2M | 1.31% | 16 |
|
|
2024
Q1 | $2.64M | Buy |
+56,402
| New | +$2.64M | 0.45% | 82 |
|
|
2023
Q4 | – | Sell |
-61,979
| Closed | -$1.84M | – | 202 |
|
|
2023
Q3 | $1.84M | Buy |
+61,979
| New | +$1.84M | 0.35% | 91 |
|